|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o A.I. Software Inc., of Vancouver, British Columbia, said it acquired all the issued and outstanding shares of Israeli stem cell research firm Pluristem Ltd. A.I. Software, which purchased Pluristem for cash obtained in a recently completed private placement, plans to change its name to Pluristem Life Systems Inc. As part of the acquisition, A.I. Software received licensing rights to stromal-cell bioreactor equipment and process that assists in the expansion of stem cells. Financial terms were not disclosed.
o Adprotech Ltd., of Cambridge, UK, was awarded orphan drug status by the FDA for APT070 in the prevention of delayed graft function in solid organ ...